RADIOTHERAPY Radioiodine in thyroid cancer-how to minimize side effects

被引：4

作者：

Reiners, Christoph ^{[1
]}

Luster, Markus ^{[2
]}

机构：

[1] Univ Hosp Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany

[2] Univ Hosp, Dept Nucl Med, D-89081 Ulm, Germany

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2012年 / 9卷 / 08期

关键词：

RECOMBINANT HUMAN THYROTROPIN; ABLATION; CARCINOMA; THERAPY; RISK;

D O I：

10.1038/nrclinonc.2012.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Life expectancy of most patients with differentiated thyroid cancer is normal, so adverse treatment effects should be minimized. Lower activities of radioiodine for ablation of thyroid remnants are non-inferior to higher activities and quality of life can be maintained by preparation of radioiodine remnant ablation using recombinant human thyrotropin. Reiners, C. & Luster, M. Nat. Rev. Clin. Oncol. 9, 432-434 (2012); published online 19 June 2012; doi:10.1038/nrclinonc.2012.101

引用

页码：432 / 434

页数：4

共 10 条

[1] Radioiodine for Thyroid Cancer - Is Less More? [J].

Alexander, Erik K. ;

Larsen, P. Reed .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18) :1732-1733

[2]

[Anonymous], SURV EP END RES

[3]

Hänscheid H, 2006, J NUCL MED, V47, P648

[4] Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer [J].

Mallick, Ujjal ;

Harmer, Clive ;

Yap, Beng ;

Wadsley, Jonathan ;

Clarke, Susan ;

Moss, Laura ;

Nicol, Alice ;

Clark, Penelope M. ;

Farnell, Kate ;

McCready, Ralph ;

Smellie, James ;

Franklyn, Jayne A. ;

John, Rhys ;

Nutting, Christopher M. ;

Newbold, Kate ;

Lemon, Catherine ;

Gerrard, Georgina ;

Abdel-Hamid, Abdel ;

Hardman, John ;

Macias, Elena ;

Roques, Tom ;

Whitaker, Stephen ;

Vijayan, Rengarajan ;

Alvarez, Pablo ;

Beare, Sandy ;

Forsyth, Sharon ;

Kadalayil, Latha ;

Hackshaw, Allan .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18) :1674-1685

[5] Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study [J].

Pacini, F ;

Ladenson, PW ;

Schlumberger, M ;

Driedger, A ;

Luster, M ;

Kloos, RT ;

Sherman, S ;

Haugen, B ;

Corone, C ;

Molinaro, E ;

Elisei, R ;

Ceccarelli, C ;

Pinchera, A ;

Wahl, RL ;

Leboulleux, S ;

Ricard, M ;

Yoo, J ;

Busaidy, NL ;

Delpassand, E ;

Hanscheid, H ;

Felbinger, R ;

Lassmann, M ;

Reiners, C .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :926-932

[6] Radioiodine for remnant ablation and therapy of metastatic disease [J].

Reiners, Christoph ;

Haenscheid, Heribert ;

Luster, Markus ;

Lassmann, Michael ;

Verburg, Frederik A. .

NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (10) :589-595

[7] Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis [J].

Sawka, Anna M. ;

Thabane, Lehana ;

Parlea, Luciana ;

Ibrahim-Zada, Irada ;

Tsang, Richard W. ;

Brierley, James D. ;

Straus, Sharon ;

Ezzat, Shereen ;

Goldstein, David P. .

THYROID, 2009, 19 (05) :451-457

[8] Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer [J].

Schlumberger, Martin ;

Catargi, Bogdan ;

Borget, Isabelle ;

Deandreis, Desiree ;

Zerdoud, Slimane ;

Bridji, Boumediene ;

Bardet, Stephane ;

Leenhardt, Laurence ;

Bastie, Delphine ;

Schvartz, Claire ;

Vera, Pierre ;

Morel, Olivier ;

Benisvy, Danielle ;

Bournaud, Claire ;

Bonichon, Francoise ;

Dejax, Catherine ;

Toubert, Marie-Elisabeth ;

Leboulleux, Sophie ;

Ricard, Marcel ;

Benhamou, Ellen .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18) :1663-1673

[9] A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal [J].

Schroeder, PR ;

Haugen, BR ;

Pacini, F ;

Reiners, C ;

Schlumberger, M ;

Sherman, SI ;

Cooper, DS ;

Schuff, KG ;

Braverman, LE ;

Skarulis, MC ;

Davies, TF ;

Mazzaferri, EL ;

Daniels, GH ;

Ross, DS ;

Luster, M ;

Samuels, MH ;

Weintraub, BD ;

Ridgway, EC ;

Ladenson, PW .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :878-884

[10] No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer [J].

Verburg, Frederik Anton ;

Stokkel, Marcel P. M. ;

Dueren, Christian ;

Verkooijen, Robbert B. T. ;

Maeder, Uwe ;

van Isselt, Johannes W. ;

Marlowe, Robert J. ;

Smit, Johannes W. ;

Reiners, Christoph ;

Luster, Markus .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (02) :276-283

← 1 →